Timeline
Ftse 100
Moonpig shares are "crazy cheap" at 9% free cash flow yield, analyst argues
Barclays US unit clears Fed stress test with capital ratios above minimums
Moonpig earnings soar 20% thanks to margin boost
Mining Today: Anglo American and Codelco seal Los Bronces-Andina copper deal, Cobra Resources, Kodal Minerals, Essentra, Kenmare Resources
Deutsche Bank lifts Diageo price target to 1759p on rising US promotional activity
SpaceX sheds $600bn from IPO peak as tech sell-off rattles Nasdaq and Kospi
Market Brief: Thalia Therapeutics acquires AML RNA therapy firm in £2.75m-backed deal, Ratio Petroleum bids for Pharos Energy, Vertu Motors, Anglo American
Anglo American and Codelco complete Los Bronces-Andina joint mine plan deal
Tech Today: Deutsche Bank sees 31% RELX upside, Big Technologies, Iomart, Filtronic
Deutsche Bank holds GSK at 1,900p as prescription tracker flags mixed product trends
Deutsche Bank sees 31% upside in RELX ahead of July results
FTSE 100 dragged lower by silver and mining selloff as dollar caps metals recovery
Eco Atlantic enters H2 with deals in a row
Pan African Resources to join FTSE 250 after Emmerson acquisition
Health & Bio Today: AstraZeneca's Truqap wins FDA approval for prostate cancer
The Premarket Brief: Reabold in takeover talks with Union Jack Oil, Frasers Group's Aussie bid, Peel Hunt, AstraZeneca
AstraZeneca's Truqap approved in US as targeted treatment for prostate cancer
Health & Bio Today: BSF Enterprise shares halve after T-Rex handbag fails at auction, Cizzle Biotechnology, GSK
GSK wins orphan drug status in US and Europe for momelotinib in rare inflammatory blood disorder with no approved treatments
Tritax Big Box REIT says Secretary of State to decide Manor Farm planning by 7 July
Health & Bio Today: GSK acquires Nuvalent for $10.6bn, Imaging Biometrics, Seaport Therapeutics, Smith+Nephew
Tech Today: Glass Lewis backs Nanoco delisting plan, Oxford Instruments, Crimson Tide, Vantiva
Oxford Instruments' Advanced Technologies secures FY27 revenue coverage after 28% order intake rise
The Premarket Brief: LBG Media cuts earnings guidance on Meta algorithm hit, Vantiva HomeSight, Imaging Biometrics, GSK, Keller
Fevertree remains confident of matching market expectations as it extends buyback
GSK to buy Nuvalent for $10.6bn to add late‑stage lung‑cancer drugs
Small Caps Today: Verici Dx, Neo Energy Metals, Brickability, Beeks, SkinBio Therapeutics ...
The Premarket Brief: Seraphim Space to join FTSE 250 after £137m raise, Neo Energy CFO suspended, BRCK Group, Pensana, Mpac Group ...
Seraphim Space Investment Trust to join FTSE 250 on 19 June
Helium One sees first offtake for Galactica’s Pinon Canyon output
Cordiant Digital Infrastructure added to FTSE 250
The Premarket Brief: ITM Power and Protium partner on UK hydrogen, Currys, B&M, Boohoo
Currys names Fredrik Tønnesen as its new Group Chief Executive
British American Tobacco says its on track as new product categories accelerate
Mining Today: Bluebird Mining's South Korea royalty deal, Aterian, First Class Metals, Forgent, Lexington Gold, Greatland Gold
Greatland Gold dips as debt facility and Havieron FID milestone reached
Health & Bio Today: CelLBxHealth wins AstraZeneca services deal, Avacta Group, AstraZeneca
CelLBxHealth shares rocket on AstraZeneca master services agreement
Small Caps Today: CelLBxHealth signs AstraZeneca services deal, Europa Oil & Gas, Tooru, Fandango, Itaconix, MedPal A and more
The Premarket Brief: CelLBxHealth signs AstraZeneca services deal, Tooru, Clean Power Hydrogen, Ocado
AstraZeneca wins US approval for Imfinzi in early high‑risk bladder cancer
Health & Bio Today: GSK, BSF Enterprise, Nuformix, Physiomics, SkinBioTherapeutics, Property Franchise Group
GSK posts positive Phase 3 results for Hepatitis B treatment
AstraZeneca says FDA extends decision date for camizestrant, allowing extra data review
Health & Bio Today: Genedrive chairman exits as Nugent joins board, Novo Nordisk, Crism, Diaceutics, CVS Group, AstraZeneca,
Harworth adds Barclays to £275m RCF syndicate
The Premarket Brief: Sound Energy sells Tendrara stake for $57m, CVS Group, Arrow Exploration, AstraZeneca, Atalaya Mining
AstraZeneca wins CHMP backing for Enhertu tumour‑agnostic approval
JD Sports Fashion publishes inaugural FY26 Global Impact Report
More in Markets
Halo Minerals posts interim loss as Playa Verde advances
The AIM-listed copper developer reported a £2.9 million first-half loss, largely non-cash, as it pushed its Chilean tailings project toward a final investment decision.